Skip to main content
Avivagen Inc. logo

Avivagen Inc. — Investor Relations & Filings

Ticker · VIV ISIN · CA05382F2026 TSXV Manufacturing
Filings indexed 552 across all filing types
Latest filing 2020-04-08 Declaration of Voting R…
Country CA Canada
Listing TSXV VIV

About Avivagen Inc.

http://www.avivagen.com

Avivagen Inc. was a life sciences corporation focused on developing and commercializing natural health products for livestock, companion animals, and humans. The company specialized in feed additives designed to support immune function and promote growth in animals, emphasizing science-based validation through clinical trials. On April 23, 2024, Avivagen Inc. filed a voluntary assignment in bankruptcy, and a trustee was appointed to manage the proceedings.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a press release announcing the results of Avivagen's Annual General Meeting (AGM) held on April 8, 2020. It details shareholder voting outcomes, including the election of directors and auditor reappointment. The content focuses on the AGM event and voting results rather than providing a full annual report or financial statements. The document length is under 5,000 characters and serves as an announcement of AGM results, not the AGM materials themselves. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-04-08 English
News release - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a press release announcing a significant new order for Avivagen's OxC-beta Livestock product. It discusses product adoption, market expansion, and forward-looking statements about future sales and market potential. There are no financial statements, regulatory filings, or detailed financial data presented. The content is typical of a Capital/Financing Update or a business development announcement rather than a formal financial report or regulatory filing. It does not fit categories like Annual Report, Earnings Release, or Regulatory Filings. Given the focus on a major order and business update, the most appropriate classification is Capital/Financing Update (CAP). The document length and content support a high confidence in this classification.
2020-04-07 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the issuance of common shares to holders of debentures in lieu of an annual maintenance fee. It details the number of shares to be issued, the rate per share, and references previous announcements about similar issuances. There is no financial statement, comprehensive financial data, or detailed report content. The document is an update on a capital transaction related to the company's financing activities, specifically the issuance of shares to satisfy a maintenance fee on debentures. This fits the definition of a Capital/Financing Update (CAP). The document length is about 5,096 characters, which is sufficient for a detailed announcement but does not constitute a full financial report or regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2020-04-02 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing new sales orders secured by Avivagen for its OxC-beta™ product in Taiwan and Thailand. It contains no financial statements, regulatory filings, or detailed financial data. It is a business update focused on sales and market expansion rather than a formal financial report or regulatory filing. There is no indication of an earnings release, annual or interim report, or any other formal filing type. The content is typical of a general corporate announcement or business update. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2020-04-02 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the first purchase orders of a product (OxC-beta Livestock) in Mexico by Avivagen Inc. It discusses sales agreements, market potential, and product details. There is no indication of financial statements, regulatory filings, or detailed financial performance data. The content is primarily a business update about sales and market expansion, not a financial report or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Capital Update. It is a general corporate announcement about sales activity and market development, which does not match any highly specific financial filing category. Therefore, the best fit is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements that do not fit other categories.
2020-03-25 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Avivagen Inc. will issue common shares to satisfy an annual maintenance fee owed to holders of secured debentures. It details the number of shares to be issued, the rate per share, and the timing of the issuance. The content focuses on a capital/financing activity related to the company's debt instruments. There is no financial statement data, no discussion of quarterly or annual results, no management discussion of financial performance, nor any regulatory filing or certification. The document is not an announcement of a report publication but a direct announcement of a financing-related transaction. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is about 4969 characters, which is sufficient for a substantive announcement. Confidence is high given the clear focus on share issuance to satisfy a debt maintenance fee.
2020-03-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.